海桐皮方凝胶贴膏联合手法治疗腰椎间盘突出症:前瞻性随机双盲安慰剂对照试验
本研究纳入40–60岁腰椎间盘突出症成人100例,随机分为海桐皮方凝胶贴膏(HTPGP)联合清代三法手法组与安慰剂贴膏联合手法组,干预2周并随访4周。结果显示HTPGP组自第7天起VAS改善显著更优,ODI评分持续更低,sEMG组间无显著差异,无严重不良事件。
要点
- HTPGP联合手法可较安慰剂更有效减轻腰椎间盘突出症慢性疼痛。
- HTPGP组功能障碍指数(ODI)改善持续优于安慰剂组。
- 表面肌电(sEMG)未见组间显著差异,安全性良好。
核心结论
- HTPGP联合手法治疗腰椎间盘突出症患者,在疼痛减轻和功能改善方面均优于安慰剂组,且安全性良好。
- 仍需更大样本的随机试验证实上述发现。
研究设计与样本
- 前瞻性、随机、双盲、安慰剂对照试验,纳入40–60岁腰椎间盘突出症成人100例,按1:1随机分配。
- 干预组接受清代三法手法联合HTPGP,对照组接受手法联合安慰剂贴膏,疗程2周,随访4周。
主要发现
- HTPGP组从第7天起VAS改善显著大于安慰剂组(Z=2.644–4.332)。
- HTPGP组ODI评分持续更低(主效应F=33.43;时间效应F=227.21;交互效应F=17.19)。
- sEMG结局未见组间显著差异,未发生严重不良事件。
关键数值与推荐
- 主要结局为视觉模拟量表(VAS)疼痛强度,次要结局包括Oswestry功能障碍指数(ODI)和表面肌电(sEMG)。
- 统计分析采用广义估计方程、重复测量方差分析和Mann-Whitney U检验。
临床怎么用
- 对于40–60岁腰椎间盘突出症慢性疼痛患者,可考虑在手法治疗基础上联合HTPGP以改善疼痛和功能。
- 治疗2周即可观察到VAS和ODI的获益趋势,但需注意sEMG未见显著改变。
局限性
- 样本量较小(100例),需更大规模随机试验确认结果。
- 随访时间较短(4周),长期疗效未知。
- sEMG未显示组间差异,机制尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Haitongpi Formula, derived from the Traditional Chinese Medicine (TCM) classic Yizong Jinjian, has shown efficacy for low back pain, fractures, and osteoarthritis. Haitongpi Formula Gel Paste (HTPGP) is a modern dosage form of this formula, but clinical evidence on its effectiveness and safety remains limited. This study was designed to evaluate the clinical efficacy and safety of HTPGP combined with manipulation in relieving chronic pain caused by lumbar disc herniation (LDH). METHODS: Adults aged 40-60 years with LDH were randomly assigned to receive Qing dynasty three-movement manipulation plus HTPGP or placebo plaster (PLAGP) for 2 weeks, with 4 weeks of follow-up. The primary outcome was pain intensity measured by the visual analog scale (VAS); secondary outcomes included the Oswestry Disability Index (ODI) and surface electromyography (sEMG). Analyses were performed using generalized estimating equations, repeated-measures ANOVA, and Mann-Whitney U tests. RESULTS: Between October 2024 and June 2025, 100 eligible participants were randomized (HTPGP vs. PLAGP, 1:1). The HTPGP group demonstrated significantly greater VAS improvement from day 7 onwards (Z = 2.644-4.332). ODI scores were consistently lower in the HTPGP group (main effect F = 33.43; time effect F = 227.21; interaction F = 17.19). No significant between-group differences were observed in sEMG outcomes, and no serious adverse events occurred. CONCLUSION: In patients with LDH, HTPGP combined with manipulation provided greater pain reduction and better functional improvement than those observed in the placebo group, with a favorable safety profile. Larger randomized trials are required to confirm these findings. TRIAL REGISTRATION: The trial was registered with the International Traditional Medicine Clinical Trial Registry (http://itmctr.ccebtcm.org.cn/; No. ITMCTR2024000077).
引用
- Wan T, Zhang G, Wen H, et al. Clinical efficacy of a Chinese herbal gel plaster combined with manipulation for lumbar disc herniation: a prospective, randomized, double-blind, placebo-controlled trial. Front Pharmacol. 2026. PMID: 41939845. doi:10.3389/fphar.2026.1708694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。